First Trust Advisors LP Purchases 7,439 Shares of HealthEquity, Inc. $HQY

First Trust Advisors LP increased its position in HealthEquity, Inc. (NASDAQ:HQY) by 24.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,086 shares of the company’s stock after buying an additional 7,439 shares during the quarter. First Trust Advisors LP’s holdings in HealthEquity were worth $3,183,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. William Blair Investment Management LLC bought a new stake in HealthEquity during the 4th quarter worth approximately $169,956,000. Norges Bank bought a new position in shares of HealthEquity during the fourth quarter valued at $66,927,000. AQR Capital Management LLC lifted its holdings in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares during the period. Wasatch Advisors LP lifted its holdings in shares of HealthEquity by 9.3% during the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after purchasing an additional 613,288 shares during the period. Finally, Millennium Management LLC grew its stake in shares of HealthEquity by 151.5% in the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the subject of a number of recent research reports. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, July 25th. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and upped their price target for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Citizens Jmp raised their price objective on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Eleven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $110.93.

Insiders Place Their Bets

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 17,905 shares of company stock worth $1,651,280. Company insiders own 1.60% of the company’s stock.

HealthEquity Trading Down 0.9%

NASDAQ:HQY opened at $103.44 on Friday. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $106.42. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The firm’s fifty day moving average is $93.03 and its 200-day moving average is $85.66. The firm has a market cap of $8.65 billion, a P/E ratio of 38.74, a P/E/G ratio of 1.76 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.